C-reactive protein levels and sleep disturbances: Observations based on the Northern Finland 1966 birth cohort study

Psychosomatic Medicine

Volumn 69, Issue 8, 2007, Pages 756-761

  Liukkonen, Timo ^a,b   Räsänen, Pirkko ^b,c   Ruokonen, Aimo ^b   Laitinen, Jaana ^d   Jokelainen, Jari ^b,c   Leinonen, Maija ^e   Meyer Rochow, V Benno ^b,f   Timonen, Markku ^b  

^a Savonlinna Central Hospital   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f JACOBS UNIVERSITY BREMEN   (Germany)

Author keywords

C reactive protein; Inflammation; Sleep; Sleep disturbances

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; ENZYME IMMUNOASSAY; EPIDEMIOLOGICAL DATA; FEMALE; FINLAND; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; SELF REPORT; SEX DIFFERENCE; SLEEP DISORDER; SMOKING; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE;

EID: 37349116952     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/PSY.0b013e318157cb96     Document Type: Article

References (53)

1. Rechtshaffen A, Bergmann BM, Everson CA, Kushida CA, Gilliland MA. Sleep deprivation in the rat: X. Integration and discussion of the findings. Sleep 2002;25:68-87.
2. Alvarez GG, Ayas NT. The impact of daily sleep duration on health: a review of literature. Prog Cardiovasc Nurs 2004;19:68-9.
3. Prinz PN. Age impairment in sleep, metabolic and immune functions. Exp Gerontol 2004;39:1739-43.
4. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998;158:1099-107.
5. Steptoe A, Peacey V, Wardle J. Sleep duration and health in young adults. Arch Intern Med 2006;166:1689-92.
6. Schwartz SW, Cornoni-Huntley J, Cole SR, Hays JC, Blazer DG, Schocken DD. Are sleep complaints an independent risk factor for myocardial infarction? AEP 1998;8:384-92.
7. Ayas NT, White DP, Manson JE, Stampfer MJ, Speitzer FE, Malhotra A, Hu FB. A prospective study of sleep duration and coronary hearth disease in women. Arch Intern Med 2003;163:205-9.
8. Nilsson PM, Rööst M, Engström G, Hedblad B, Bereglund G. Incidence of diabetes in middle-aged men is related to sleep disturbance. Diabetes Care 2004;10:2464-9.
9. Knutson KL, Ryden AM, Mander BA, Cauter EV. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006;166:1768-74.
10. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
11. Åkerstedt T, Nilsson PM. Sleep as restitution: an introduction. J Intern Med 2003;254:6-12.
12. Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, Nieto FJ. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005;165:863-7.
13. Motivala SJ, Sarfatti A, Olmos L, Irwin MR. Inflammatory markers and sleep disturbance in major depression. Psychosom Med 2005;67:187-94.
14. Shearer WT, Reuben JM, Mullington JM, Price JN, Lee B-M, O'Brian-Smith E, Szuba MP, Van Dongen PA, Dinges DF. Soluble TNF-α receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 2001;107:165-70.
15. Vgontzas AN, Zoumakis E, Bixlex O, Lin H-M, Follet H, Kales A, Chrousos GP. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004;89:2119-26.
16. Vgontzas AN, Zoumakis E, Bixlex O, Lin H-M, Prolo P, Vela-Bueno A, Kales A, Chrousos GP. Impaired night time sleep in healthy old versus adults is associated with elevated plasma interleukin-6 and cortisol levels: physiological and therapeutic implications. J Clin Endocrinol Metab 2003;88:2087-95.
17. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers if inflammation. Arch Intern Med 2006;166:1756-62.
18. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Hearth J 2005;46:801-9.
19. Meier-Ewert KH, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004;4:678-83.
20. Larkin EK, Rosen CL, Kirchner HL, Stolfer-Isser A, Emancipator JL, Johnson NL, Zambito AM, Tracy RP, Jenny NS, Redline S. Variation of C-reactive protein levels in adolescent. Circulation 2005;111:1978-85.
21. McDade, TW, Hawkey LC, Cacioppo JT. Psychosocial and behavioural predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosom Med 2006;68:376-81.
22. Rantakallio P: Groups at risk in low birth weight infants and perinatal mortality. Acta Paediatr Scand 1969;193(Suppl):1-71.
23. Rantakallio P. The longitudinal study of the Northern Finland birth cohort of 1966. Pediatr Perinat Epidemiol 1988;2:59-88.
24. Sorri M, Järvelin M-R. Well-being and health. Background to the Northern Finland 1966 birth cohort research. Int J Circumpolar Health 1998;57:82-3.
25. Timonen M, Jokelainen J, Hakko H, Silvennoinen-Kassinen S, Meyer-Rochow VB, Herva A, Räsänen P. Atopy and depression: the Northern Finland 1966 Birth Cohort Study. Mol Psychiatry 2003;8:738-44.
26. Sintonen H. The 15D Instrument of health-related quality of life: properties and applications. Ann Med 2001;33:328-36.
27. Taponen S, Martikainen H, Järvelin MR, Sovio U, Laitinen J, Pouta A, Hartikainen, AL, McCarthy MI, Franks S, Paldanius M, Ruokonen A. Northern Finland birth cohort 1966 study. Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study. J Clin Endocrinol Metab 2004;89:2114-8.
28. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Räsänen P, Leinonen M, Meyer-Rochow VB, Timonen M. The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol Psychiatry 2006;60:825-30.
29. Elovainio M, Keltikangas-Jarvinen L, Pulkki-Raback L, Kivimaki M, Puttonen S, Viikari L, Rasanen L, Mansikkaniemi K, Viikari J, Raitakari OT. Cardiovascular risk in young Finns study; depressive symptoms and C-reactive protein: the cardiovascular risk in young Finns study. Psychol Med 2006;36:797-805.
30. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the third national health and nutrition examination survey. Arch Intern Med 2004;164:1010-14.
31. Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med 2003;65:347-56.
32. Derogatis LR, Lipman RS, Covi C. SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull 1973;9:13-27.
33. Winokur A, Winokur DF, Rickels K, Cox DS. Symptoms of emotional distress in family planning service: stability over four week period. Br J Psychiatry 1984;144:395-9.
34. Nettelbladt P, Hansson L, Stefansson CG, Borgquist L, Nordstrom G. Test characteristics of the Hopkins symptom checklist-25 (HSCL-25) in Sweden, using the present state examination (PSE-9) as a caseness criterion. Soc Psychiatry Psychiatr Epidemiol 1993;28:130-3.
35. Sandanger I, Moum T, Ingebrigtsen G, Dalgard OS, Sörengen T, Bruusgard D. Concordance between symptom checklist-25 and the composite international diagnostic interview I. Soc Psychiatry Psychiatr Epidemiol 1998;33:345-54.
36. Knutson KL. Sex differences in the association between sleep and body mass index in adolescents. J Pediatr 2005;147:830-4.
37. Kaneita Y, Ohita T, Takemura S, Sone T, Suzuki K, Miyake T, Yokoyama E, Umeta T. Relation of smoking and drinking to sleep disturbance among Japanese pregnant woman. Prev Med 2005;41:877-82.
38. Visovsky C, Dvorak C. Exercise and cancer recovery. Online Journal of Issues in Nursing 2005;10. Available at http//nursingworld.org/ojin/hirsh/ topics3/tpc3_2htm.
39. Averina M, Nilssen O, Brenn T, Brox J, Arkhipovsky VL, Kalinin AG. Social and lifetime determinants of depression, anxiety, sleeping disorder self-evaluated quality of life in Russia - a population-based studying Arkangelsk. Soc Psychiatry Psychiatr Epidemiol 2005;40:511-8.
40. James JE, Gregg ME. Hemodynamic effects of dietary caffeine, sleep restriction, and laboratory stress. Psychophysiology 2004;41:914-23.
41. Wolk R, Gami AS, Garcia-Touchard A, Somers VK. Sleep and cardiovascular disease. Curr Probl Cardiol 2005;30:625-6.
42. Aziz N, Fahey JL, Detels R, Butch AW. Analytic performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clin Diagn Lab Immunol 2003;4:652-7.
43. Koenig W, Sund M, Fröchlich M, Fischer H-G, Löwel H, Döring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg cohort Study, 1984 to 1992. Circulation 1999;99:237-42.
44. Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, Palmer LJ, Hattersley AT, Ebrahim, Lowe GD, Rumley A, Davey SG. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 2005;366:1954-9.
45. Dreon DM, Slavin JL, Phinney SD. Oral contraceptive use and increased plasma concentration of C-reactive protein. Life Sci 2003;73:1245-52.
46. Huber P. Robust estimation of a location parameter. Ann Math Stat 1964;35:73-101.
47. Li G. Robust regression. In: Hoaglin DC, Mosteller F, Tukey JW, eds. Exploring Data Tables, Trends, and Shapes. New York, NY: John Wiley & Sons Inc.; 1985.
48. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003;157:940-3.
49. Penninx BWJH, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry 2003;54:566-72.
50. Macy ME, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52-8.
51. Veijola J, Jokelainen J, Läksy K, Kantojärvi L, Kokkonen P, Järvelin M-R, Joukamaa M. The Hopkins symptom checklist-25 in screening DSM-III-R axis-I disorders. Nord J Psychiatry 2003;57:119-23.
52. Späth-Schwalbe E, Hansen K, Scmidt F, Schrezenmeier H, Marshall L, Burger K, Fehm HL. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 1998;83:1573-79.
53. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, Wians FH Jr, Grundy SM, de Lemos JA. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005;46:464-9.